XYZ Pharmaceutical, Inc. just got FDA approval for their new drug, Viagrina. The
ID: 2740954 • Letter: X
Question
XYZ Pharmaceutical, Inc. just got FDA approval for their new drug, Viagrina. The company has never paid a dividend, but they expect to pay one for the first time by the end of the year. The expected dividend is $3.00 per share and the company expects that dividend to increase at a rate of 20% for five years. After that, XYZ expects to see its dividend growth limited by the growth rate the US economy, which on average is 4.5% per year. If the required rate of return for other startup pharmaceutical companies like XYZ is 11%, what should be the fair price of XYZ’s stock today? please show me how to do this on my financial calculator
Explanation / Answer
First work out the cash-flows -
Year 1 - 3
Year 2 - 3 * 1.21 = 3.6
Year 3 - 3 * 1.22 = 4.32
Year 4 - 3 * 1.23 = 5.18
Year 5 - 3 * 1.24 = 6.22
Year 6 - 3 * 1.25 = 7.46
The high growth period ends at Year 6, so we also need to find the terminal value = D6 (1+g) / (Ke-g)
= 7.46 * 1.045 / (0.11-0.045)
= 120.51
Thus, the total cash-flows for year 6 = 7.46 + 120.51 = 127.97
Now, all the cash-flows can be entered into a financial calculator such as Texas BA II Plus -
Related Questions
Navigate
Integrity-first tutoring: explanations and feedback only — we do not complete graded work. Learn more.